Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
AstraZeneca announces co-promotion agreement with Daiichi Sankyo for NEXIUM in Japan
-
AstraZeneca Third Quarter and Nine Months Results 2010
-
AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as a treatment for severe sepsis
-
European regulator backs nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
-
Positive agreement received for approval of VIMOVO in Europe
-
New outcomes study for ticagrelor (BRILINTA™) to examine longer-term treatment for post- ACS patients
-
AstraZeneca initiates phase III clinical development of fostamatinib for the treatment of rheumatoid arthritis
-
Results of Zibotentan Phase III trial in castration resistant prostate cancer
-
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
-
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
Latest articles and press releases
All of our latest press releases and articles are available to explore
